News - Verastem

Filter

Current filters:

Verastem

Popular Filters

US orphan designation for defactinib in mesothelioma

25-07-2013

US cancer drug developer Verastem (Nasdaq: VSTM) says that its lead cancer stem cell inhibitor, VS-6063…

BiotechnologydefactinibOncologyPharmaceuticalRegulationResearchVerastem

Defactinib plus paclitaxel positive in platinum-resistant ovarian cancer

23-07-2013

US cancer drug developer Verastem (Nasdaq: VSTM) has announced the confirmation of a complete response…

BiotechnologydefactinibOncologyResearchVerastem

Back to top